Highlights:
- Late-breaking presentations from the European Stroke Organisation Conference (ESOC) progress clinical data on tenecteplase as an alternative intravenous thrombolysis drug to alteplase, and the treatment of basilar artery occlusion stroke with endovascular therapy
- Johanna Fifi (New York, USA) and Richard Perry (London, UK) discuss the relationship between COVID-19 infection and stroke, which remains a complex and uncertain topic more than two years on from the start of the pandemic
- A debate from this year’s Charing Cross (CX) Symposium reveals that audience members are yet to be fully convinced by the existing body of evidence on transcarotid artery revascularisation
- Profile: Pedro Lylyk (Buenos Aires, Argentina)
- Neuromodulation: Transcranial direct current stimulation shows promise as a therapeutic option in autism patients—when used alongside cognitive remediation training
